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Abstract
Psoriasis is a common inflammatory skin disease involving a cross-
talk between epidermal and immune cells. The role of specific
epidermal stem cell populations, including hair follicle stem cells
(HF-SCs) in psoriasis is not well defined. Here, we show reduced
expression of c-JUN and JUNB in bulge HF-SCs in patients with
scalp psoriasis. Using lineage tracing in mouse models of skin
inflammation with inducible deletion of c-Jun and JunB, we found
that mutant bulge HF-SCs initiate epidermal hyperplasia and skin
inflammation. Mechanistically, thymic stromal lymphopoietin
(TSLP) was identified in mutant cells as a paracrine factor stimu-
lating proliferation of neighboring non-mutant epidermal cells,
while mutant inter-follicular epidermal (IFE) cells are lost over
time. Blocking TSLP in psoriasis-like mice reduced skin inflamma-
tion and decreased epidermal proliferation, VEGFa expression, and
STAT5 activation. These findings unravel distinct roles of HF-SCs
and IFE cells in inflammatory skin disease and provide novel mech-
anistic insights into epidermal cell interactions in inflammation.
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Introduction
The epidermis is a stratified epithelium undergoing constant
renewal due to the presence of stem cells (Alberts et al, 2002). It is
composed of the inter-follicular epidermis (IFE), which consists of
layers of keratinocytes, hair follicles, and associated sebaceous and
sweat glands (Fuchs, 2008). Within the IFE, epidermal stem cells
are localized in the basal cell layer. Upon commitment to terminal
differentiation, basal stem cells asymmetrically divide giving rise to
post-mitotic suprabasal layers establishing an epidermal barrier
(Fuchs, 2008). In addition to the IFE, distinct regions in the hair
follicle contain hair follicle stem cells (HF-SCs), such as the bulge,
isthmus and junctional zone of hair follicle, and sebaceous glands
(Liu et al, 2003; Horsley et al, 2006; Jensen et al, 2009). Differential
expression of specific markers characterizes the different stem cell
subpopulations, allowing the study of their specific contributions to
different aspects of cell behavior. For instance, in mice, HF-SCs in
the bulge region express CD34, while both HF-SCs and IFE basal
keratinocytes express integrin-a6 (CD49f; Liu et al, 2003; Trempus
et al, 2003; Horsley et al, 2006, 2008; Jaks et al, 2008; Jensen et al,
2009; Snippert et al, 2010). These different stem cell populations
from IFE and hair follicles also have distinct roles during skin
remodeling, wound healing, and homeostasis. For example, during
homeostasis, committed progenitor cells (transit-amplifying kerati-
nocytes) of the IFE maintain the tissue renewal, while HF-SCs
remain largely quiescent until the onset of HF growth (Ito et al,
2005; Blanpain & Simons, 2013). During wound healing and acute
inflammation, both IFE epidermal stem cells and K15+ bulge HF-
SCs contribute to early wound re-epithelialization by increasing
their proliferation rates, thereby expanding the pool of progenitor
cells that migrate out of the follicles toward the wound (Ito et al,
2005; Levy et al, 2005; Arwert et al, 2012; Mascre et al, 2012; Blan-
pain & Simons, 2013). Furthermore, it is reported that basal and
squamous skin cell carcinomas arise from K15+ bulge HF-SCs
(Trempus et al, 2007; Lapouge et al, 2011; Schober & Fuchs, 2011;
Wang et al, 2011). However, little is known about the specific
contribution of K15+ bulge HF-SCs and IFE stem cells to the devel-
opment of chronic inflammatory skin diseases such as psoriasis.
Psoriasis is a common heterogeneous inflammatory disease of
unknown etiology, with an estimated worldwide prevalence of 3%
in the population (Wagner et al, 2010). The vast majority of patients
develop a chronic “plaque-type” psoriasis referred to as psoriasis
vulgaris. The most common sites of psoriasis are the elbows, knees,
forearms, shins, retro-auricular regions, and scalp (Wolf-Henning
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Boehncke, 2015). Scalp psoriasis is the most common type of psoria-
sis, representing 50% of the cases of psoriatic patients (Icen et al,
2009). Approximately 75–90% of patients with plaque-type psoriasis
in other areas also develop psoriasis in the scalp (Ortonne et al,
2009). Psoriatic plaques are characterized and perpetuated by
hyper-proliferation of keratinocytes, impaired differentiation and
permanent infiltration of neutrophils and T cells (Wagner et al,
2010). Many studies have focused on immunological aspects of the
disease; however, treatments against immunological targets are not
completely effective, and recurrence and chronicity prevail. In an
epidermal context, it has been demonstrated that human transit-
amplifying keratinocytes in psoriatic plaques exhibit increased
proliferation and a reduced apoptotic rate, fostering epidermal
hyper-proliferation and altered differentiation in situ and in vitro
(McKay & Leigh, 1995; Truzzi et al, 2011). However, it remains
unclear which epidermal lineages give rise to psoriasis, since a
longitudinal analysis of the behavior of psoriatic keratinocytes in
human patients is not achievable.
Genetically engineered mouse models (GEMMs) of psoriasis have
been generated to mimic various aspects of the disease (Wagner
et al, 2010). We have previously generated an inducible epidermal-
specific double knockout mouse model by epidermal deletion of c-
Jun and JunB using the K5 promoter (referred as DKO*). This model
develops a psoriasis-like disease within 2 weeks after induction,
exhibiting several psoriatic hallmarks including hyper- and paraker-
atosis, inflammatory infiltrate, elevated levels of cytokines/
chemokines, increased subepidermal vascularization, and some co-
morbidities like bone loss and arthritic joints (Zenz et al, 2005). Our
goal in this study is to elucidate the specific contribution of different
epidermal stem cell populations during the development of psoria-
sis-like disease, by applying a novel strategy to simultaneously track
the IFE and K15+ bulge HF-SCs stem cell lineages in the DKO*-psor-
iasis-like mouse model. This model allows us to permanently label
different cell populations involved in the development of psoriasis-
like disease in vivo, and to investigate the specific role of each popu-
lation during disease initiation and development. Using this new
mouse model, we found that a small fraction of K15+ bulge HF-SCs
can initiate a psoriasis-like disease. Mutant bulge HF-SCs are able to
survive, whereas IFE cells disappear during disease progression.
Furthermore, mutant bulge HF-SCs and basal keratinocytes secrete
thymic stromal lymphopoietin (TSLP), which induces proliferation
of neighboring non-mutant keratinocytes. These results emphasize
the heterogeneity of epidermal stem cells and their role in psoriasis-
like development, and define a mechanistic basis for epidermal
hyperplasia through TSLP paracrine signaling.
Results
c-JUN and JUNB levels are reduced in bulge hair follicle stem
cells (HF-SCs) from scalp psoriasis patients
Previous results have reported alterations in the expression levels of
c-JUN and JUNB in the inter-follicular epidermis (IFE) of psoriatic
plaques from human patients (Zenz et al, 2005); however, it is not
known whether the expression levels of c-JUN and JUNB are
affected in epidermal stem cells. While there are no specific markers
to identify IFE stem cells, keratin 15 (K15)-positive cells represent
the vast majority of HF-SCs located in the bulge of hair follicles (Liu
et al, 2003; Purba et al, 2014). Another marker that identifies puta-
tive bulge HF-SCs in human HFs is CD200 (Purba et al, 2014). We
analyzed the expression of c-JUN and JUNB in the bulge region of
HFs from scalp psoriatic patients, a common form of human psoria-
sis (Figs 1 and EV1A). K15 was highly expressed in hair follicles,
and low expression was also found in some basal keratinocytes of
the scalp epidermis (Fig 1A and B). K15+ basal cells located in the
outer root sheath (ORS) of the bulge region showed significantly
reduced expression of c-JUN and JUNB in lesional hair follicles in
anagen phase (38 and 12%, respectively), while c-JUN and JUNB
were expressed in 70 and 50%, respectively, in non-lesional hair
follicles and healthy scalp (Fig 1A–J). The reduction was confirmed
in putative bulge HF-SCs identified by the surface marker CD200
(Fig EV1A).
Only bulge HF-SCs exhibited reduced c-JUN/JUNB expression,
while basal and suprabasal ORS layers in the sub-bulge and proxi-
mal bulb regions maintained the expression of c-JUN/JUNB
(Fig EV1B and C). In addition, other regulators of HF-SC renewal
from other regions in the hair follicle, such as GATA-6, expressed in
progenitor matrix cells (bulb) in mice were analyzed (Wang et al,
2017). Interestingly, GATA-6 was up-regulated in suprabasal ORS
layers in the bulge region from psoriatic lesional scalps, while no
differences were observed in GATA-6-positive cells from the proxi-
mal bulb (Fig EV1C). These findings show that scalp psoriasis is
associated with a reduction of c-JUN and JUNB in bulge HF-SCs
along with GATA-6 increased expression.
Epidermal stem cell lineage tracing in the DKO* psoriasis-like
mouse model
The differential expression of c-JUN and JUNB in CD200+/K15+
bulge HF-SCs in human samples of psoriatic plaques directed us to
explore the potential causal contribution of epidermal stem cell
populations to the initiation and development of psoriasis. To this
end, we applied mouse genetics to ablate the expression of c-Jun
and JunB, first globally in all epidermal stem cell populations
present in both the basal layer of the IFE and hair follicle units
during homeostasis (Byrne et al, 1994). We crossed the well-estab-
lished DKO* psoriasis-like mouse model (Zenz et al, 2005) with the
mT/mG fluorescent reporter mouse. The psoriasis-like phenotype in
DKO*-mT/mG mice was induced by the genetic deletion of c-Jun
and JunB floxed alleles in K5+ basal keratinocytes and K5+ epider-
mal stem cells after tamoxifen administration. This treatment also
induced an irreversible replacement of the constitutive Tomato
expression (red) by the expression of GFP only in K5+ basal kerati-
nocytes and K5+ epidermal stem cells (Fig 2A), allowing tracing of
epidermal stem cells and their progeny (transient-amplifying and
differentiated keratinocytes) during psoriasis progression. Mice
expressing Cre recombinase under the control of the K5 promoter
with wild-type or heterozygous c-Jun and JunB were used as
controls (Co-mT/mG).
We first analyzed the labeling efficiency and epidermal speci-
ficity of GFP in Co-mT/mG ear skin 15 days after tamoxifen injec-
tion. Without tamoxifen, 95  5% of epidermal cells expressed
Tomato and only few keratinocytes expressed GFP (Fig EV2A).
Following tamoxifen treatment, Tomato expression decreased and
GFP expression increased by ~ 60–70% in K5+ epidermal cells of
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IFE, hair follicles, and sebaceous glands (Fig EV2B, upper panels).
DKO*-mT/mG mice treated with tamoxifen developed a psoriasis-
like phenotype 2 weeks after induction, mainly in the ears, head,
paws, and tail, as previously reported (Zenz et al, 2005). We next
analyzed the expression of GFP in this psoriasis-like DKO*-mT/mG
ear skin. Interestingly, although hyperplasia was present throughout
the epidermis, only small patches of hyperplastic keratinocytes
expressed GFP in IFE, hair follicles, and sebaceous glands, showing
a mosaic pattern of mutantGFP-positive keratinocytes among a
majority of non-mutantTom-positive keratinocytes (Fig EV2B, lower
panels). We confirmed that the deletion of c-Jun and JunB occurred
only in mutantGFP epidermal cells using fluorescence microscopy
(Fig EV2C). Therefore, our tracing system successfully allows study-
ing the dynamics of mutantGFP epidermal stem cells and their
progenitor cells, and non-mutantTom epidermal stem cells and their
progenitor cells in this psoriasis-like mouse model.
Mutant and non-mutant IFE keratinocytes exhibit
different proliferation and apoptosis rates during
psoriasis-like development
To further understand the mosaic deletion pattern in the DKO*-mT/
mG psoriasis-like mouse model, we traced GFP expression after
tamoxifen injection during the initiation (day 0–5), mid-term (day
7–9), and late-term (day 15–30) stages of the disease (Fig 2B). Initial
epidermal cells labeled for GFP+ at day 0 after the last injection
with tamoxifen are observed in isolated groups of cells in IFE and
hair follicles (Figs 2C and EV2D). Composite images of whole
ear sections showed that mutantGFP keratinocytes are increased at
5–7 days followed by a drastic reduction at days 15–30, whereas
immune cell infiltration and epidermal thickening sharply increased
over time (Fig 2C and D; Appendix Fig S1A–C).
We then analyzed apoptosis and proliferation by cleaved
caspase-3 (cCas3) and Ki67 expression, respectively. Apoptosis was
observed in mutantGFP and non-mutantTom keratinocytes from the
IFE of DKO*-mT/mG mice during psoriasis-like progression,
although at day 7 after induction, the apoptosis rate was higher in
mutantGFP keratinocytes (38%), when compared to non-mutantTom
keratinocytes (10%) (Fig 2E, upper panel). Interestingly, 78% of
non-mutantTom keratinocytes expressed Ki67 vs. 40% of mutantGFP
keratinocytes, suggesting a proliferative advantage of non-
mutantTom keratinocytes (Fig 2E, lower panel). The rapid loss of
mutantGFP keratinocytes in the ear skin of DKO*-mT/mG mice was
also confirmed by intravital confocal imaging analyses at day 7 after
induction (Fig 2F and G, and Movie EV1). Overall, these findings
suggest that the psoriasis-like phenotype in the IFE of DKO*-mT/mG
mice is characterized by different proliferation and apoptotic rates of
distinct mutant and non-mutant populations during psoriasis-like
progression.
The global proliferation/apoptosis imbalance led to almost
complete depletion of mutantGFP basal and suprabasal keratinocytes
in the IFE at the latest stage (day 15–30). This drastic loss could
imply that the psoriasis-like phenotype should also decrease over
time. However, the psoriasis-like phenotype is sustained until the
late term of disease progression (D30) (Fig 2D). Interestingly,
remaining mutantGFP keratinocytes at the late term of disease
progression were located in the outer root sheath (ORS) in both hair
follicles and in adjacent IFE keratinocytes (Fig 2H and I). In fact,
same dynamic pattern of GFP/Tomato cells was observed in the IFE
of tail and back skin during psoriasis development in DKO* mice
(Appendix Fig S2). Interestingly, mutant GFP+ hair follicles from
tail psoriatic skin underwent anagen induction suggesting the acti-
vation of these mutantGFP HF-SCs in psoriasis-like disease. Our next
goal was to further investigate the contribution of these HF-asso-
ciated mutantGFP keratinocytes during psoriasis-like progression.
Deletion of c-Jun/JunB in bulge HF-SCs is sufficient for the
development of inflammatory skin disease
Bulge HF-SCs are an important stem cell population for wound heal-
ing and for the initiation and maintenance of skin carcinomas, and
are characterized by the expression of K15 and the surface marker
CD34 in mice. We hypothesized that the remaining mutantGFP kera-
tinocytes observed in the ORS of the hair follicles and in adjacent
IFE regions are mainly derived from mutant HF-SCs. To test this
hypothesis, we first conducted FACS analyses to determine the
proportion of the different HF-SC subpopulations expressing CD34,
CD49f, and Sca-1 markers (Jensen et al, 2010) in the ear skin of the
Co-mT/mG and DKO*-mT/mG mice during the psoriasis-like
progression (Appendix Fig S3A). As expected, the number of
mutantGFP basal IFE cells decreased during disease progression,
whereas non-mutantTom basal and suprabasal IFE cells increased
over time (Appendix Fig S3B and C). With regard to the hair folli-
cles, the number of mutantGFP HF-SCs from bulge and junctional
zone was increased twofold during disease progression, whereas
the number of non-mutantTom HF-SCs decreased over time
(Appendix Fig S3D–F). To confirm that CD34+ mutantGFP cells
belong to bulge HF-SCs and not to the IFE epidermis, we conducted
histological section and ear whole-mount confocal analyses and
observed co-expression of GFP+ and CD34+ cells only in the bulge
region of hair follicles (Fig EV3A and Appendix Fig S4A). Interest-
ingly, both bulge HF-SC populations (mutantGFP and non-mutantTom)
had reduced mRNA levels of the quiescence transcription factors
Foxc1 and Nfatc1 (Horsley et al, 2008; Wang et al, 2016; Fig EV3B
◀ Figure 1. Scalp psoriasis exhibits reduced expression of c-JUN and JUNB in hair follicle stem cells (HF-SCs).A–D Representative composite immunofluorescence images of whole hair follicle units from non-lesional and lesional scalp psoriasis patients. K15 (green), c-JUN (red in
A, C) and JUNB (red in B, D) and DAPI (blue).
E–H Confocal images of the bulge region of human psoriatic hair follicles from non-lesional and lesional regions of the scalp. K15 (green), c-JUN (red in E, G) and JUNB
(red in F, H) and DAPI (blue).
I, J Percentage of HF-SCs (K15+) that express c-JUN (I) and JUNB (J) in the bulge region of human psoriatic hair follicles from non-lesional and lesional scalp in
comparison with healthy scalp. n = 2–6 hair follicles in anagen per group from five psoriatic patients and two healthy patients. Data represent mean  SD.
Statistical significance *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s two-tailed t-test relative to controls). See Appendix Table S2 for exact P-values.
Source data are available online for this figure.
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and C), suggesting an activation of bulge HF-SCs during psoriasis
progression. In fact, FACS-isolated CD34+ mutantGFP bulge HF-SCs
displayed an increased clonogenic capacity in vitro, compared to
non-mutantTom bulge HF-SC counterparts and control bulge HF-SCs
(Fig EV3D and Appendix Fig S4B). Overall, all these findings
suggest that bulge HF-SCs are activated and exit quiescence in the
psoriasis-like disease.
We then investigated whether mutantGFP keratinocytes from
bulge HF-SCs are sufficient to induce and maintain skin inflamma-
tion. We generated a new DKO* model to specifically target K15+
HF-SCs and termed it DKO*K15-mT/mG. This was achieved by
crossing mice carrying the floxed JunB (JunBf/f) and c-Jun (c-Junf/f)
alleles with a transgenic mouse line expressing the Cre recombi-
nase–prostaglandin receptor fusion under the control of keratin 15
promoter (K15-Cre-PGR; Liu et al, 2003). After mifepristone (RU-
486) treatment, this model allowed the specific targeting of K15+
HF-SCs in the bulge to delete c-Jun and JunB and to render targeted
cells to become GFP positive (Fig 3A). Interestingly, DKO*K15-mT/
mG mice developed a similar psoriasis-like phenotype as the DKO*
mouse model 2 weeks after induction, displaying similar histologi-
cal and chronological features in the skin at day 30 of the disease
(Fig 3B–E). However, the psoriasis-like severity was less
pronounced in DKO*K15 mice when compared to the DKO* mice.
The expression of specific pro-inflammatory cytokines/alarmins,
such as IL-17A, IL-6, and lipocalin-2 (LCN2), was higher in the
serum of DKO* mice compared to DKO*K15 mice at day 30 after
psoriasis-like induction (Fig 3F–H). These cytokines and LCN2 were
significantly increased in DKO*K15 mice in comparison with control
mice, suggesting a mild systemic inflammatory process in the HF-SC
DKO*K15 psoriasis-like mouse model. We next analyzed the
dynamic GFP expression in the DKO*K15-mT/mG ear skin and
compared it to DKO*-mT/mG mice during psoriasis-like progres-
sion. At day 0 after the last injection with mifepristone, the majority
of hair follicles are labeled for GFP including some isolated spots
found in the IFE (Fig EV3E). During initiation of the psoriasis-like
disease (day 5), 20% of mutantGFP epidermal cells derived from
mutantGFP K15+ bulge HF-SCs were quantified by FACS analysis
(CD45CD49f+CD34 epidermal total population), whereas
mutantGFP epidermal cells derived from mutantGFP K5+ basal kerati-
nocytes/HF-SCs was increased by 35–50% (Fig 3I). In contrast,
during late stages of the psoriasis-like disease (day 15–30), the
percentage of mutantGFP epidermal cells was only twofold reduced
in DKO*K15 mice (from 20 to 10%), whereas in DKO* mice, it was
drastically reduced fivefold at days 15–30 (from 35–50 to 8%).
Immunofluorescence analyses for c-Jun and JunB expression con-
firmed that the mutantGFP keratinocytes derived from mutantGFP
K15+ bulge HF-SCs did not express c-Jun or JunB (Fig EV3F). Inter-
estingly, DKO*K15-mT/mG psoriatic-like mice showed the same
mosaic pattern of green and Tomato epidermal cells than the one
previously described in the DKO* mouse model at the late term of
psoriasis-like development (Fig 3J). In fact, a similar proliferation
pattern of mutantGFP and non-mutantTom keratinocytes was
observed in both models, although the apoptosis rate of mutantGFP
keratinocytes was reduced in DKO*K15-mT/mG mice when
compared to DKO*-mT/mG mice (Figs 3K and 2E).
Overall, these data show that the specific inactivation of c-Jun
and JunB in bulge HF-SCs is sufficient to induce a psoriasis-like
phenotype in the DKO*K15-mT/mG mice. Importantly, these data
uncovered that bulge HF-SCs may act as a reservoir of new mutant
epidermal cells, sustaining epidermal hyperplasia and skin
inflammation, thereby recapitulating the observed skin phenotype
of DKO* mice at later time points (Fig EV3G).
Keratinocytes derived from mutantGFP HF-SCs have increased cell
survival compared to mutantGFP keratinocytes derived from IFE
To determine whether keratinocytes derived from mutantGFP bulge
HF-SCs behave differently than IFE mutantGFP basal keratinocytes
◀ Figure 2. Mutant and non-mutant inter-follicular keratinocytes have different proliferation and apoptotic rates during psoriasis-like disease progression.A Schematic representation of the JunB and c-Jun double knockout mouse model (DKO*) with lineage tracing used to investigate the psoriasis-like disease development
in mice. Briefly, DKO* psoriasis-like mouse model was generated by the cross of mice carrying the floxed JunB allele (JunBf/f) and floxed c-Jun allele (c-Junf/f) with the
transgenic mice expressing the Cre recombinase–estrogen receptor fusion under the control of the basal keratinocyte-specific K5 promoter (K5-Cre-ERT) to obtain
JunBf/f c-Junf/f K5-Cre-ERT mice. To trace epidermal-specific deletion of JunBf/f and c-Junf/f in DKO* mice, global double-fluorescent Cre reporter mouse Gt(ROSA)
26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (referred as mT/mG) was crossed with DKO* mice (referred as DKO*-mT/mG).
B Experimental timeline to induce psoriasis-like disease in 8-week-old mice with four consecutive doses of tamoxifen injections (2 mg). Upon induction, non-mutant
keratinocytes express Tomato, while mutant keratinocytes express GFP. GFP expression was analyzed at 0, 5, 7, 15, and 30 days post-induction.
C Composite immunofluorescence images showing GFP expression of whole ear sections from DKO*-mT/mG mice at day 5, 7, 15, and 30. Increased GFP expression is
shown at day 7 followed by progressive decrease of GFP+ keratinocytes (white dotted line represents basal layer, and red dotted line represents outermost skin layer).
n = 3 per time point.
D Quantification analysis of GFP expression (top) and epidermal thickness (bottom) of DKO* mice at different time points during psoriasis-like disease progression.
n = 6 per time point. Data represent mean  SD. Statistical significance **P < 0.01, ***P < 0.001 (Student’s two-tailed t-test relative to control group). See
Appendix Table S2 for exact P-values.
E Quantification analysis of cleaved caspase-3 (cCas3, top) and Ki67 (bottom) in ear skin of DKO* mice at different time points during psoriasis-like disease progression.
n = 3 per time point. Data represent mean  SD. Statistical significance *P < 0.05, ***P < 0.001 (Student’s two-tailed t-test). See Appendix Table S2 for exact P-
values.
F Intravital confocal time-lapse imaging of non-mutant Tomato keratinocytes and mutant GFP keratinocytes of DKO*-mT/mG at day 7 after first tamoxifen injection.
Dotted circles emphasize areas in which mutant GFP+ keratinocytes are replaced by non-mutant Tomato+ keratinocytes.
G Percentage of GFP+ area eliminated during intravital confocal time-lapse imaging at day 5, 7, and 15 in DKO*-mT/mG mice (Time-lapse 1:8 h). Positive value: Area of
GFP increased. Negative value: Area of GFP reduced.
H Fluorescence imaging of DKO*-mT/mG ear skin at day 30 after first tamoxifen injection shows that remaining mutant GFP+ keratinocytes reside along the hair
follicles. White dotted line separates epidermis and dermis. White arrows represent GFP+ hair follicles.
I Intravital confocal time-lapse imaging of DKO*-mT/mG at day 15 after first tamoxifen injection. Mutant GFP+ keratinocytes (white arrows) are maintained around
hair follicles. White arrows represent GFP+ hair follicles.
Source data are available online for this figure.
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(b-KCs), we FACS-isolated and cultured these two populations at
low concentration of 2,000 cells/cm2, as well as GFP+ bulge HF-SCs
and b-KCs from Co-mT/mG mice as controls (Fig 4A). Next, we
conducted a time-lapse confocal microscopy analysis of small colo-
nies after 3 days in culture to evaluate the activity of different cell
populations. Interestingly, over a 48-h time course, mutantGFP KCs
derived from mutantGFP bulge HF-SCs showed similar growth
compared to controlGFP KCs from bulge HF-SCs (Fig 4B), while
mutantGFP b-KCs had a rapid growth during the first 24 h followed
by a drastic decrease in cell number due to cell death compared to
controlGFP b-KCs (Fig 4C and Movie EV2). These results show that
the same mutation in primary keratinocytes from distinct epidermal
stem cell populations induces different proliferation and survival
phenotypes, and suggest that bulge HF-SCs play a major role in the
maintenance of the psoriasis-like disease.
Secreted factors from mutantGFP keratinocytes induce hyper-
proliferation of neighboring non-mutantTom keratinocytes
We have shown that in both psoriasis-like mouse models, DKO*-
mT/mG and DKO*K15-mT/mG, non-mutantTom KCs mainly sustain
epidermal hyperplasia. We hypothesized that the establishment of
cell–cell interactions between mutantGFP KCs and non-mutantTom
KCs primed the non-mutantTom population to increase their prolifer-
ation, leading to chronic hyperplasia in the psoriasis-like disease. To
determine if the hyper-proliferation of non-mutantTom KCs is condi-
tioned by the presence of mutantGFP KCs, we co-cultured sorted
mutantGFP bulge HF-SCs and mutantGFP b-KCs with their corre-
sponding non-mutantTom bulge HF-SC and b-KC counterparts
(Fig 4D). MutantGFP KCs derived from both bulge HF-SC and b-KC
populations were able to stimulate the proliferation of co-cultured
neighboring non-mutantTom KCs (Fig 4E and F, and Movie EV3).
This increase in the proliferation of Tomato+ KCs was also observed
when mutantGFP bulge HF-SCs and mutantGFP b-KCs were co-
cultured with controlTom bulge HF-SC and b-KC counterparts
(Appendix Fig S5A and B). In addition, non-mutantTom bulge
HF-SCs conditioned the proliferation of mutantGFP bulge HF-SCs,
whereas non-mutantTom b-KCs did not affect the proliferation of
mutantGFP b-KCs (Fig 4E and F). Interestingly, mutantGFP KCs from
b-KCs also induced an increased cell death in neighboring non-
mutant/controlTom KCs, while mutantGFP KCs from bulge HF-SCs
did not induce a significant increase in cell death of their non-
mutant/controlTom KC counterparts (Appendix Fig S5C and D). To
determine whether the observed increased proliferation and cell
death are a result of a direct cell–cell contact rather than stimulation
by secreted factors, we cultured b-KCs in trans-wells, in which the
non-mutantTom b-KCs were cultured at the bottom of the plate and
the mutantGFP b-KCs were cultured on the trans-well inserts. We
observed similar cell proliferation and death rates as the ones
observed in the co-cultures, suggesting that cell–cell contact is not
required for the hyper-proliferation of non-mutantTom KCs (Fig 4G).
These observations suggest an induction of a proliferative advantage
in non-mutantTom KCs by paracrine factors secreted from mutantGFP
KCs, independently of their origin from the hair follicle or IFE during
the psoriasis-like progression in the DKO* mouse model.
Mutant and non-mutant epidermal stem cells display different
molecular signatures
To gain insight into the potential molecular mechanisms that govern
the behavior of the distinct mutant and non-mutant bulge HF-SCs
and IFE cell populations during the progression of the psoriasis-like
disease, we performed mRNA sequencing analyses. We FACS-
isolated GFP+, Tomato+ bulge HF-SCs and b-KCs from DKO*-mT/
mG mice, and their counterpart populations from control mice at
the mid-term of the psoriasis-like progression (Fig EV4A). Interest-
ingly, non-mutantTom populations exhibited a higher differential
gene expression (972 total genes in HF-SCs and 632 total genes in
b-KCs) than the one observed in mutantGFP populations (701 total
genes in HF-SCs and 444 total genes in b-KCs) (Fig 5A, upper
panel). A Venn diagram including these differentially expressed
genes (DEG) was generated to depict the results in each population
◀ Figure 3. Inactivation of c-Jun and JunB in bulge HF-SCs is sufficient to initiate psoriasis-like development.A Experimental timeline showing the different time points analyzed after mifespristone induction (day 5, 7, 15, and 30, green) to evaluate GFP expression in ear skin
from control (CoK15-mT/mG) and mutant (DKO*K15-mT/mG) mice.
B Ear pictures of control, DKO*, and DKO*K15 mice after 15 days of induction show clear signs of inflammation and psoriatic-like scales in both models.
C Representative images of hematoxylin and eosin (H&E) staining of ear sections from control, DKO*, and DKO*K15 mice.
D Ear thickness measurement at different time points during psoriasis-like development in control, DKO*, and DKO*K15 mice. n > 5 per group. Data represent mean  SD.
Statistical significance *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s two-tailed t-test relative to control group). See Appendix Table S2 for exact P-values.
E FACS quantification of CD45+ cells from ear skin of control, DKO*, and DKO*K15 mice at different time points during psoriasis-like development. n > 5 per group.
Data represent mean  SD. Statistical significance *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s two-tailed t-test relative to controls). See Appendix Table S2 for
exact P-values.
F–H Quantification of IL-17A, IL-6, and LCN2 production in sera of control, DKO*, and DKO*K15 mice at day 30 of psoriasis-like disease by ELISA. n > 4 per group. Data
represent mean  SD. Statistical significance *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s two-tailed t-test relative to controls). See Appendix Table S2 for exact
P-values.
I Quantification of total number of GFP+ epidermal cells by FACS analysis from DKO*-mT/mG and DKO*K15-mT/mG mice at different time points during psoriasis-like
progression compared to Co-mT/mG mice. n = 3–6 per group and time point. Data represent mean  SD. Statistical significance **P < 0.01 (Student’s two-tailed
t-test relative to control group). See Appendix Table S2 for exact P-values.
J Representative immunofluorescence images of ear sections from CoK15-mT/mG and DKO*K15-mT/mG mouse models after 15 days of induction. Red (Tomato), green
(GFP), and blue (DAPI). Hyperplasia of Tomato+ keratinocytes in psoriatic-like DKO*K15-mT/mG mouse with clusters of GFP+ keratinocytes is derived from hair
follicle K15+ GFP+ stem cells. n = 3 per group. Dotted lines separate epidermis and dermis.
K Quantification analysis of cleaved caspase-3 (cCas3) and Ki67 in ear skin of DKO*K15-mT/mG mice at different time points during psoriasis-like disease progression.
n = 3–5 per group. Data represent mean  SD. Statistical significance *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s two-tailed t-test). See Appendix Table S2 for
exact P-values.
Source data are available online for this figure.
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Figure 4. Differential behavior of inter-follicular and follicular stem cells.
A Schematic representation of cell sorting and single culture conditions. GFP+ bulge hair follicle stem cells (HF-SCs, CD34+ CD49fhigh) and GFP+ basal keratinocytes
(b-KC, CD49fhigh) from ear skin of Co-mT/mG and DKO*-mT/mG mice were collected at day 10 after tamoxifen induction, sorted by FACS, and cultured at low density
(2,000 cells/cm2) during 3–5 days as primary cultures. Time-lapse imaging of six fields was performed during 48 h, once small colonies of 5–10 cells were observed.
B Average number of live and dead (TOPRO-3+ DAPI+) primary keratinocytes derived from HF-SCGFP at different time points of time-lapse capture during 48 h. There is a
slight increase over time of live HF-SCs from DKO* mice when compared to control cells, and no difference in average of dead cells. n = 4 fields from two
independent experiments. Data represent mean  SD. Non-statistical significance (two-way ANOVA and Bonferroni post-test).
C Average number of live and dead (TOPRO-3+ DAPI+) primary keratinocytes derived from basal keratinocytesGFP show a significant increase in DKO* basal live
keratinocytes at 12 h, followed by a significant increase in cell death at 48 h. n = 4 fields from two independent experiments. Data represent mean  SD. Statistical
significance *P < 0.05 (two-way ANOVA and Bonferroni post-test).
D Schematic representation of cell sorting and co-culture conditions. GFP+ and Tom+ bulge HF-SCs (CD34+ CD49fhigh) and GFP+ and Tom+ basal keratinocytes
(CD49fhigh) from ear skin of Co-mT/mG and DKO*-mT/mG collected at day 10 after tamoxifen induction were sorted by FACS and co-cultured (same proportion of GFP
and Tom cells) at low density (2,000 cells/cm2) during 3–5 days. When small colonies of 5–10 cells were formed, time-lapse imaging of six fields was performed
during 48 h.
E Average number of live primary keratinocytes from co-cultures of GFP+ with Tomato+ bulge HF-SCs at different time points of time-lapse capture during 48 h. Co-
culture of HF-SCGFP with HF-SCTom from DKO*-mT/mG mice shows a significant increase of HF-SCTom, while the HF-SCTom from DKO*-mT/mG mice show a normal
growth when they are co-cultured with HF-SCGFP from control mice. n = 4 fields from two independent experiments. Data represent mean  SD. Statistical
significance ***P < 0.001 (two-way ANOVA and Bonferroni post-test).
F Average number of live primary keratinocytes from co-cultures of GFP+ with Tomato+ basal keratinocytes at different time points of time-lapse capture during 48 h.
Co-culture of b-KCGFP with b-KCTom from DKO*-mT/mG mice shows significant increase of b-KCTom, while these b-KCTom from DKO*-mT/mG mice show a normal
growth when they are co-cultured with b-KCGFP from control mice. n = 4 fields from two independent experiments. Data represent mean  SD. Statistical
significance ***P < 0.001 (two-way ANOVA and Bonferroni post-test).
G Average total number of live Tomato+ basal keratinocytes (from DKO* or control mice) at different time points cultured in the bottom part of trans-well system
cultures with GFP+ basal keratinocytes (from DKO* or control mice) cultured in the upper trans-well (Tw). n = 5 fields from three independent experiments. Data
represent mean  SD. Tom+ basal keratinocytes significantly increased when these were cultured with mutant GFP+ basal keratinocytes in the trans-well in
comparison with control GFP+ basal keratinocytes. Statistical significance *P < 0.05, ***P < 0.001 (two-way ANOVA and Bonferroni post-test).
Source data are available online for this figure.
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(Fig EV4B and C). In fact, the bulge HF-SC population displayed
more up-regulated genes, including genes specifically up-regulated
in non-mutantTom HF-SCs (> 400 genes), mutantGFP HF-SCs (> 150
genes) and genes commonly up-regulated in both populations of
HF-SCs (GFP/TOM > 200 genes; Fig 5A). Conversely, the mutant b-
KC population presents the majority of down-regulated genes
(> 200 genes; Fig 5A), whereas around 100 common genes were up-
regulated in all cell populations (Fig 5A).
Next, we conducted gene ontology (GO) analyses, to identify the
specific enrichment of the obtained genetic signatures in different
biological processes, focusing attention on the bulge HF-SCs up-/
down-regulated genes and on the common genes up-regulated in all
cell populations (Figs 5B, and EV4D and E). The most prominent
biological process enriched in the genetic signatures of all cell popu-
lations are related to neutrophil degranulation and chemotaxis,
chronic inflammatory responses, and epidermal cell differentiation
(Fig EV4D). These findings support our prior findings observed
in vivo and in vitro, where non-mutantTom KCs acquire psoriasis-like
hallmarks without having c-Jun and JunB mutation.
MutantGFP bulge HF-SCs displayed a specific enrichment of genes
encoding pro-inflammatory mediators in psoriasis, in particular an
increase in genes related to arachidonic acid (AA) metabolism, such
as Ptgs2 (Figs 5B and EV4F), and specific pro-inflammatory cytoki-
nes, such as Tnf-a, Il-23, and Il1-a (Fig EV4G–I), whereas genes
related to epithelial cell migration were down-regulated (Fig EV4E).
In contrast, non-mutantTom bulge HF-SCs showed an enrichment of
genes related to angiogenesis, VEGF receptors, extracellular matrix
disassembly, and epithelial cell migration and proliferation (Fig 5B).
Both mutantGFP and non-mutantTom bulge HF-SCs shared up-regu-
lated genes related to mitotic cell cycle and asymmetric cell division
(Fig 5B). These results are in agreement with our previous observa-
tions that both bulge HF-SC populations were active during psoriasis
progression. In addition, other pro-inflammatory cytokines
important in psoriasis, such as Il-6, were only up-regulated in
non-mutantTom cell populations (Fig EV4J), and we also observed
that Il-1b was significantly up-regulated in non-mutantTom b-KCs
(Fig EV4K). These data suggest that mutantGFP bulge HF-SCs
have an important pro-inflammatory role in the initiation of psoria-
sis-like disease and unravel the expression of a unique transcrip-
tomic profile of non-mutantTom bulge HF-SCs in the development of
psoriasis.
We next investigated the differential expression of genes coding
for secreted proteins in mutantGFP populations of bulge HF-SCs
and b-KCs, since our in vitro results showed that mutantGFP cell
populations secreted paracrine factors that induced the prolifera-
tion of non-mutantTom KCs. Four secreted proteins were overex-
pressed Tslp, Psors1c2, Fetub, and Lif (Fig 5C). All four proteins
are involved in systemic inflammation and TSLP, PSORS1C2 and
LIF in inflammatory skin diseases (Asumalahti et al, 2000; Szepi-
etowski et al, 2001; He et al, 2008). Thymic stromal lymphopoi-
etin (TSLP) is known for its important role in allergies and atopic
dermatitis (He et al, 2008), and it is up-regulated in the epidermis
of psoriatic patients (Volpe et al, 2014). We detected a 12-fold
increase in mutantGFP bulge HF-SCs and a fivefold increase in
mutantGFP b-KCs at the early/mid-term (D7) of the psoriasis-like
development (Fig 5C). Interestingly, while the expression of TSLP
remained increased in mutantGFP bulge HF-SCs and mutantGFP b-
KCs at the mid-term of the psoriasis-like development, its
expression was reduced at the latest stage (D30) (Fig 5D and E).
In contrast, an increased expression of TSLP in non-mutantTom
bulge HF-SCs was observed at D30, while non-mutantTom b-KCs
did not express TSLP at any stage of psoriasis-like development
(Fig 5D and E). Furthermore, TSLP was increased in sera of both
psoriasis-like mouse models, DKO* and DKO*K15, at day 30 after
psoriasis-like induction (Fig 5F). These results suggest that the
secretion of TSLP may contribute to psoriasis-like initiation and
maintenance in DKO* and DKO*K15 mice. In summary, the RNA-
seq analyses revealed the heterogeneity and complexity of different
epidermal stem cell populations during psoriasis-like disease initia-
tion and progression.
TSLP secreted by mutantGFP keratinocytes induces hyper-
proliferation of non-mutantTom keratinocytes leading to
epidermal hyperplasia
To mechanistically explore the effect of the pro-inflammatory TSLP
protein on non-mutantTom KC proliferation, we first induced the
deletion of c-Jun and JunB in primary DKO*-mT/mG KC cultures by
infecting cells with Adenovirus-Cre or empty Adenovirus (control).
We observed that 24 h after infection, 50% of KCs were GFP+ and
deficient for c-Jun and JunB expression, while the other 50% were
Tomato+ KCs and maintained the expression of c-Jun and JunB. To
assess the causal involvement of TSLP on non-mutant KCs prolifera-
tion, cells were treated with a blocking TSLP antibody for three
consecutive days after Adenovirus infection (Fig 6A). The Adeno-
Cre-infected cells significantly increased the amount of TSLP in
conditioned media, when compared to Adeno-empty-infected
control cells (Fig 6B). This correlated with a significant increase in
the proliferation of non-mutantTom KCs present in the Adeno-Cre-
infected cell cultures, when compared to Adeno-empty control cells,
while the hyper-proliferation was blocked by the addition of 1 lg/ml
TSLP antibody (Fig 6C). In order to test whether TSLP is sufficient
to induce proliferation in KCs, recombinant TSLP was added at dif-
ferent concentrations (Fig EV5A and B) to primary wild-type (WT)
KCs. Primary WT KCs expressed TSLPR in culture and increased
proliferation rate after recombinant TSLP treatment, even at low
concentrations. Interestingly, primary WT KCs derived from bulge
HF-SCs (CD34+) significantly increased the proliferation rate rather
than basal KCs (CD49f+) in comparison with their control cells
(Fig EV5C) suggesting that bulge HF-SCs are more sensitive to
TSLP. These data show that the proliferation of non-mutant KCs is
dependent on TSLP secretion from mutant KCs. TSLP exerts its biolog-
ical effects by binding to a high-affinity heteromeric complex
composed of TSLP receptor chain and IL-7Ra. Blocking TSLP led to
down-regulation of TSLPR chain in co-cultures, while the IL-7ra chain
increased possibly as a compensatory mechanism (Fig 6D and E). We
also observed that VEGFa expression, a pro-inflammatory mediator in
psoriasis, decreased with anti-TSLP treatment (Fig 6F). To determine
the TSLP autocrine/paracrine regulation in co-cultures of mutantGFP
with non-mutantTom KCs, we purified by FACS GFP+ and Tomato+
KCs after TSLP neutralization and analyzed gene expression of pro-
inflammatory mediators in psoriasis-like disease (Fig EV5D–M). We
confirmed the reduction of TSLP receptor expression and overexpres-
sion of Il-7ra in both populations, mutantGFP and non-mutantTom KCs,
but statistically significant in mutantGFP KCs (Fig EV5E and F). In
addition, VEGFa was increased in mutantGFP and non-mutantTom KCs
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after Adeno-Cre infection, while its expression was down-regulated
after TSLP neutralization in both populations (Fig EV5G). Interest-
ingly, Il-6 was increased only in non-mutantTom KCs after the induc-
tion with Adeno-Cre and was reduced after blocking with TSLP
antibody (Fig EV5H). Other pro-inflammatory cytokines and media-
tors, such as IL-1b and p65 (NF-jB), increased only in mutantGFP KCs
after c-Jun/JunB deletion with the consecutive reduction after TSLP
neutralization (Fig EV5I and J). Furthermore, IFN-c or G-CSF was up-
regulated in both populations, GFP and Tom KCs; however, only
mutantGFP KCs responded to TSLP neutralization (Fig EV5K and L).
S100A9 increased in both populations, higher in mutantGFP KCs, but
its expression was not reduced after blocking TSLP (Fig EV5M). These
data suggest that TSLP acts as autocrine and paracrine factor in the
cross-talk between mutant and non-mutant KCs and regulates the
expression of different pro-inflammatory mediators.
To determine whether local neutralization of TSLP reduces
epidermal cell proliferation and psoriasis-like progression in vivo,
intradermal injections of TSLP antibody were applied to the right
ear of both mouse models, DKO* and DKO*K15, 5 days after psoria-
sis-like induction (Fig 6G). Anti-TSLP treatment ameliorated psoria-
sis-like plaque formation, ear thickness, and trans-epidermal water
loss (TEWL) in both mouse models, significantly in DKO* mice
(Fig 6H–J) but not in DKO*K15 mice (Appendix Fig S6A and B). In
order to determine whether this disease amelioration was caused by
the reduction of epidermal cell proliferation and/or by reduction in
the inflammatory response, FACS analyses were performed to quan-
tify proliferative epidermal cells (Fig 6K) and immune cells infiltra-
tion (Appendix Fig S6C and D) from the ear of DKO* and DKO*K15
mice. Proliferating epidermal cells were significantly reduced in
both mouse models after anti-TSLP treatment (Fig 6K), confirmed
by a reduction of epidermal hyperplasia and proliferation by Ki67
expression in ear sections (Fig 6L). Furthermore, the number of
neutrophils on the treated ears was reduced in DKO* mice, but less
in DKO*K15 mice (Appendix Fig S6C and D).
The JAK/STAT signaling pathway through TSLP/TSLPR has been
widely studied for the activation of dendritic cells in allergies/in-
flammatory diseases such as atopic dermatitis or airway allergies
(Rochman et al, 2010). We next analyzed the expression of STAT3
and STAT5 phosphorylation (p-STAT3, p-STAT5) by immunofluo-
rescence in ear sections of psoriasis-like mice treated with anti-TSLP
or IgG (Appendix Fig S6E). DKO* mice treated with anti-TSLP had
decreased epidermal thickness and STAT5 phosphorylation, while
p-STAT3 remained unaffected in both models, suggesting that TSLP
acts through p-STAT5.
Overall, these data show that TSLP secretion by bulge HF-SCs
and mutant basal keratinocytes stimulates neighboring epidermal
cells to hyper-proliferate, activate p-STAT5 and induce expression of
VEGFa and IL-6, contributing to the initiation of epidermal hyper-
plasia and the maintenance of chronic skin inflammation observed
in psoriasis lesions. Autocrine regulation by TSLP secretion may
activate pro-inflammatory mediators, such as NF-jB, IL-1b, and G-
SCF in mutant bulge HF-SCs and mutant basal keratinocytes, push-
ing the inflammatory signaling toward psoriasis progression.
TSLP increases in hair follicles and IFE of scalp psoriasis patients
Finally, we analyzed the expression levels of TSLP in human scalp
psoriasis patients (Fig 7). TSLP was expressed along the ORS in
homeostasis of non-lesional or healthy scalp, while IFE did not
show any expression. In contrast, TSLP expression level was
increased in lesional areas with psoriasis in both compartments, IFE
and hair follicles (Fig 7A–C). Interestingly, bulge HF-SCs labeled
with CD200 did not express TSLP in psoriasis patients, neither
lesional nor non-lesional scalp, while sub-bulge ORS increased its
expression in lesional HFs (Fig 7D and E).
Discussion
It is well established that Jun/AP-1 transcription factors are
involved in chronic skin inflammation. Reduced expression of
JUNB/c-JUN in lesional regions of the inter-follicular epidermis
(IFE) of psoriatic patients might be critical for the development of
the disease (Zenz et al, 2005) despite the high variability in the
expression of these factors (Haider et al, 2006; Park et al, 2009;
Guinea-Viniegra et al, 2014). Using an epidermal lineage tracing
approach in skin inflammatory mouse models with inducible epider-
mal deletion of c-Jun and JunB, we show that mutant bulge hair
follicle stem cells (HF-SCs) are sufficient to initiate and maintain
disease development, whereas mutant IFE cells, also initiators of the
disease, are lost during psoriasis-like progression. The lesional
psoriasis-like areas of the mouse IFE displayed a mosaic pattern of
cells expressing c-Jun/JunB, which is highly reminiscent to the
observed variability in expression of JUNB/c-JUN in psoriatic
plaques of patients (Haider et al, 2006; Park et al, 2009; Guinea-
Viniegra et al, 2014). Interestingly, the analyses of human scalp
psoriatic patients show for the first time a significant reduction in
the levels of c-JUN and JUNB specifically in bulge HF-SCs,
◀ Figure 5. Different molecular signatures of mutant and non-mutant epidermal stem cells (EpSCs).A Differentially expressed genes (DEGs) from the four subpopulations (bulge HF-SCGFP; bulge HF-SCTom; b-KCGFP; and b-KCTom) from psoriatic DKO*-mT/mG mice in
comparison with their control counterparts (Co). The graphs represent the number of genes differentially up-regulated or down-regulated specifically in each group
of interest obtained by Venn diagram analysis (Fig EV4B and C).
B Heat map for specific genes relative to biological process enriched based on Gene Ontology IDs for DEGs that are: (i) exclusively up-regulated in HF-SCGFP;
(ii) exclusively up-regulated in HF-SCTom; (iii) commonly up-regulated in HF-SCGFP and HF-SCTom.
C Prediction of secreted proteins enriched in GFP+ subpopulations by the analysis of DEG commonly up-regulated in HF-SCGFP and b-KCGFP by ProteINSIDE analysis
of RNA-seq.
D, E Gene and protein expression of TSLP in different epidermal cell subpopulations sorted at mid-term (D7) or late term (D30) of psoriasis-like progression in DKO*
mice. n = 2–3. Data represent mean  SD. Statistical significance *P < 0.05, **P < 0.01 (Student’s two-tailed t-test relative to control groups). See
Appendix Table S2 for exact P-values.
F Quantification of TSLP production in sera of control, DKO*, and DKO*K15 mice at day 30 of psoriasis-like disease by ELISA. n = 4 per group. Data represent
mean  SD. Statistical significance *P < 0.05, **P < 0.01 (Student’s two-tailed t-test relative to controls). See Appendix Table S2 for exact P-values.
Source data are available online for this figure.
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supporting our hypothesis that AP-1 transcription factors in the
bulge may control HF-SC homeostasis.
The data from the mouse models suggest that the inducible dele-
tion of c-Jun and JunB in HF-SCs can initiate and maintain psoria-
sis-like plaques in ear skin, the epidermal hyperplasia and
inflammatory features of the disease, but it does not fully recapitu-
late the systemic effects observed in the DKO* psoriasis-like mice.
These differences provide a unique opportunity to study separately
the specific systemic features derived from mild/moderate psoriasis
in DKO*K15 mice vs. severe psoriasis-like disease in DKO* mice,
including different target treatments in two complementary mouse
models. Furthermore, these genetic modifications in IFE or HF-SCs
might also reflect the high variability of the disease severity and
psoriasis types in human patients, in which some patients show
small psoriatic plaques with mild severity, while others develop
multiple psoriatic plaques and co-morbidities.
An important finding using lineage tracing and cell dynamic
studies in these mouse models is the distinct behavior of different
epidermal stem cell populations during disease initiation and
progression. Interestingly, the inflammatory skin disease is
sustained mainly by non-mutant keratinocytes, while IFE mutant
keratinocytes, basal and suprabasal, may contribute to the initia-
tion, but not to the progression of the disease. Recent studies
demonstrated that the epidermis is able to correct aberrant growth
and inflammation to maintain tissue homeostasis through the elimi-
nation of damaged/mutant epidermal cells (Brown et al, 2017;
Kashiwagi et al, 2017). However, in both psoriasis-like mouse
models, although mutant IFE cells are eliminated over time, the
chronic skin inflammation is perpetuated by the survival of mutant
HF-SCs. We propose that the expression of c-Jun and JunB is dif-
ferentially regulated in distinct stem cell populations in the epider-
mis and that specific disruptions in the levels of these AP-1 factors
are important in HF-SCs, which enhance their survival and promote
the development of psoriasis-like disease.
Importantly, mutant HF-SCs have an inflammatory transcriptomic
signature distinct from other epidermal populations. For instance,
several pro-inflammatory cytokines and arachidonic acid metabolic
pathways described to be critical in psoriasis, such as IL-23 (Rizzo
et al, 2011), IL-1a (Sanmiguel et al, 2009), TNF-a (Kock et al, 1990;
Kumari et al, 2013), TSLP (Volpe et al, 2014), or PTGS2 (Samuelsson,
1991), were up-regulated. A recent report showed that during hair
follicle regeneration, CD34+ bulge HF-SCs displayed up-regulated
expression levels of genes involved in the regulation of the cell cycle
and inflammatory responses, such as TNF-a and IL-23 (Hoeck et al,
2017). The aberrant up-regulation of a pro-inflammatory signaling
cascade in mutant HF-SCs may be sufficient to increase cell survival
and the acquisition of a psoriasis-like phenotype, not only in mutant
HF-SCs, but also in neighboring non-mutant cells. Interestingly, some
arachidonic acid metabolites can regulate the survival of different
adult stem cell populations (Widera et al, 2006; Porter et al, 2013).
Furthermore, these pro-inflammatory mediators may also be involved
in the recruitment of inflammatory cells, such as dendritic cells,
neutrophils, or T cells (Albanesi et al, 2018).
Similarly, mutant epidermal cells can also stimulate neighboring
non-mutant epidermal cells to trigger hyperplasia in a paracrine fash-
ion. In both mouse models, we show that non-mutant keratinocytes
acquire a proliferative advantage, which is induced by paracrine
factors secreted by mutant keratinocytes such as TSLP. TSLP is a cyto-
kine expressed by epithelial cells, including keratinocytes, and plays
an important role in allergic inflammation, such as atopic dermatitis
(AD) (He et al, 2008). Overproduction of TSLP was found in keratino-
cytes of human AD skin lesions (Soumelis et al, 2002) and in psoriasis
patients (Volpe et al, 2014). Most studies focus on the role of TSLP in
activating inflammatory cells, such as dendritic cells, although its role
in epidermal cell–cell communication is not well understood. Our data
indicate that TSLP secretion from mutant keratinocytes enhances cell
proliferation and VEGFa expression in non-mutant keratinocytes, an
effect that was found reduced by neutralizing TLSP. We have
◀ Figure 6. TSLP secreted by mutantGFP epidermal cells induces hyper-proliferation of non-mutantTom keratinocytes.A Experimental design for induction of mutantGFP KCs in vitro and neutralization of secreted TSLP by anti-TSLP. Primary keratinocytes were cultured from the skin of
Junblox/lox; c-Junlox/lox; RosaKi/+; and K5cre-ERT+/+ mice. 50% of mutantGFP KCs were induced by infection with Cre Adenovirus, the non-infected cells were non-
mutantTom KCs. Adeno-empty was used as control. EdU was added for 5 h to label proliferating Tomato+ cells in 6-day co-culture. Quantification was performed by
confocal imaging analysis.
B TSLP production in conditioned media quantified by ELISA three days after infection with Ad-empty or Ad-cre. n = 3 independent experiments. Data represent
mean  SD. Statistical significance ***P < 0.001 (Student’s two-tailed t-test relative to control group). See Appendix Table S2 for exact P-values.
C Percentage of EdU+ Tomato+ keratinocytes after blocking with anti-TSLP. Anti-TSLP neutralizes the hyper-proliferation of non-mutantTom KCs in vitro after infection
with Ad-cre. n = 3 independent experiments, six fields per experiment. Data represent mean  SD. Statistical significance *P < 0.05 (two-way ANOVA and Bonferroni
post-test).
D Gene expression of Tslpr after TSLP neutralization is reduced. n = 3 independent experiments. Data represent mean  SD. Statistical significance *P < 0.05
(Student’s two-tailed t-test relative to control group). See Appendix Table S2 for exact P-value.
E Gene expression of IL-7ra after TSLP neutralization is increased. n = 3 independent experiments. Data represent mean  SD. Statistical significance *P < 0.05
(Student’s two-tailed t-test relative to control group). See Appendix Table S2 for exact P-value.
F Gene expression of VEGFa after TSLP neutralization is reduced. n = 3 independent experiments. Data represent mean  SD. Statistical significance *P < 0.05,
**P < 0.01 (Student’s two-tailed t-test relative to control groups). See Appendix Table S2 for exact P-value.
G Experimental design for TSLP neutralization in vivo. TSLP neutralization was performed by triple intradermal injections of 20 lg of anti-TSLP or IgG to the right ears
of DKO* and DKO*15 mice 5 days after psoriasis-like induction. EdU was added into mice by IP injection 2 h before euthanasia.
H Representative images of treated ears after 9 days of anti-TSLP or IgG treatment.
I, J Longitudinal analysis of ear thickness (I) and trans-epidermal water loss (TEWL) (J) in DKO* mice at different time points during psoriasis-like disease progression.
Data represent mean  SD. n = 4. Statistical significance *P < 0.05 (two-way ANOVA and Bonferroni post-test).
K Percentage of EdU+ epidermal cells (CD45CD49f+) after blocking with anti-TSLP in DKO* and DKO*15 mice. DKO* n = 4 and DKO*15 n = 3 per group. Data represent
mean  SD. Statistical significance *P < 0.05 (two-way ANOVA and Bonferroni post-test).
L Representative immunofluorescence images of ear sections from control or DKO* mice treated with IgG or anti-TSLP and stained for Ki67. Ki67 expression was
reduced in mice treated with anti-TSLP (n = 3).
Source data are available online for this figure.
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previously reported in the DKO* mouse model that treatment with
anti-VEGF antibody ameliorates the disease (Schonthaler et al, 2009)
and epidermal-specific VEGFa overexpression in transgenic mice leads
to spontaneous chronic skin inflammation (Xia et al, 2003). Impor-
tantly, during psoriasis-like disease initiation, TSLP is produced by
mutant HF-SCs and at late stage also by non-mutant HF-SCs. These
mutant HF-SCs also up-regulate several kallikreins (Klk7 and Klk14),
and elevated Klk expression in keratinocytes results in significantly
enhanced protease activity and augmentation of TSLP levels (Briot
et al, 2010; Bin et al, 2011). Local administration of anti-TSLP in
psoriasis-like mice resulted in the reduction of the phenotype due to
epidermal hyperplasia regression and inhibition of STAT-5 phospho-
rylation (p-STAT5) in the epidermis. The activation of STAT-5 by
TSLP has been described to play an important role in survival and
proliferation of CD4+ T cells in allergic/inflammatory skin and airway
disorders (Rochman et al, 2010). However, phosphorylation of STAT3
in epidermal cells and immune cell infiltration remained equally acti-
vated in both mouse models, suggesting that epidermal proliferation
induced by TSLP in psoriasis-like disease maybe acting through acti-
vation of STAT5, and not STAT3 phosphorylation. These novel find-
ings extend the role of TSLP to the regulation of keratinocyte
proliferation in psoriasis-like progression, which is an important hall-
mark in psoriasis. Interestingly, scalp psoriasis patients overexpressed
TSLP in the IFE and in the ORS of the sub-bulge region of HFs;
however, bulge HF-SCs did not express TSLP. CD34 labels sub-bulge
cells in human HFs, but bulge HF-SCs are negative for this marker and
positive for CD200 (Purba et al, 2014). Whether CD34 sub-bulge
populations in human HFs or other stem cell populations respond to
TSLP is still unsolved. The specific response to TSLP by different stem
cell subpopulations in the hair follicles of psoriatic patients as well as
potential cross-talk between cell populations will require further
investigation. In addition, further investigations will be required to
determine whether local neutralization of TSLP in combination with
specific HF-SCs pro-inflammatory mediators such as PGE2 could be
an effective treatment for psoriasis.
In conclusion, our study describes a novel contribution of epider-
mal stem cells in psoriasis-like development and provides insights into
new cellular and molecular mechanisms underlying the disease. These
findings open new avenues for further investigations toward discover-
ing novel therapies against psoriatic HF-SCs, which might be benefi-
cial for treating specifically psoriasis from different skin regions.
Materials and Methods
Human psoriasis biopsies
A total of seven scalp human biopsies were obtained in this study.
Five were obtained from psoriatic patients with lesional scalp
psoriasis and non-lesional scalp psoriasis from the same patient,
and two healthy scalp samples from occipital scalp region of volun-
teer hair transplant patient. All samples were obtained through
informed consent after protocol approval by the Clinical Research
Ethical Committees of Hospital Donostia and the University of Las
Palmas de Gran Canaria, and the experiments conformed to the
principles set out in the WMA Declaration of Helsinki and the
Department of Health and Human Services Belmont Report. Scalp
biopsies were harvested using between 1 and 4 mm diameter punch
(at least with a hair follicle unit). Scalp biopsies were directly
embedded in optimal cutting temperature (OCT) compound for
frozen sections, or fixed 24–48 h with neutral buffered 4%
paraformaldehyde (PFA) and directly paraffin-embedded. Five-
micrometer sections were stained either with hematoxylin and eosin
(H&E) or processed for immunofluorescence staining (see below).
Generation of lineage tracing system in psoriasis-like
mouse models
All mouse experiments were performed in accordance with the royal
decree D53/2013 on the protection of animals used for scientific
purposes (DIRECTIVE 2010/63/EU), and the Ethical Committee of
the Health Institute Carlos III, “authorized Body” by the Comunidad
de Madrid (CAM), has evaluated and approved all the procedures
involving animal experimentation for this project.
The generation of the DKO* psoriasis-like mouse model has
previously been described (Zenz et al, 2005). Briefly, DKO* psoria-
sis-like mouse model with mix background was generated by the
cross of mice carrying the floxed JunB allele (JunBf/f) and floxed c-
Jun allele (c-Junf/f) with the transgenic mice expressing the Cre
recombinase–estrogen receptor fusion under the control of the basal
keratinocyte-specific K5 promoter (K5-Cre-ERT) to obtain JunBf/f
c-Junf/f K5-Cre-ERT mice. DKO*K15 psoriasis-like mouse model was
generated by the cross of mice carrying the floxed JunB allele
(JunBf/f) and floxed c-Jun allele (c-Junf/f) with the transgenic mice
expressing the Cre recombinase–prostaglandin receptor fusion
under the control of the bulge hair follicle stem cell-specific keratin
15 promoter (K15-Cre-PGR) to obtain JunBf/f c-Junf/f K15-Cre-PGR
mice.
To trace epidermal-specific deletion of JunBf/f and c-Junf/f in
DKO* and DKO*K15 mice, global double-fluorescent Cre reporter
mouse Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (referred as
mT/mG: membrane-Tomato/membrane-Green) was crossed with
DKO* and DKO*K15 mice (referred as DKO*-mT/mG and DKO*K15-
mT/mG). Mice expressing Cre recombinase under the control of the
K5 promoter or K15 promoter with wild-type (+/+) or heterozy-
gous (+/f) for JunB and c-Jun were used as controls (CoK5-mT/mG
and CoK15-mT/mG, respectively). Eight-week-old mutant mice and
controls (males and females) were injected daily (intraperitoneal),
◀ Figure 7. Scalp psoriasis patient skin shows increased expression of TSLP in hair follicles and epidermis.A Representative composite immunofluorescence images of whole hair follicle units by confocal from non-lesional and lesional scalp psoriasis patients. c-JUN
(purple), K-15 (green), TSLP (red), and DAPI (blue). Asterisks represent the epidermis and arrows hair follicles.
B, C TSLP intensity measurement in hair follicle units and epidermis by ImageJ from healthy scalp, non-lesional, and lesional scalp psoriasis patients. Representation of
fold change relative to control healthy scalp. n = 3 samples. Data represent mean  SD. Statistical significance *P < 0.05, ***P < 0.001 (Student’s two-tailed
t-test). See Appendix Table S2 for exact P-values.
D, E Representative composite immunofluorescence images of whole hair follicle units by confocal from non-lesional and lesional scalp psoriasis patients (D) and
magnification images of specific regions from the HFs (E). CD200 (green), c-JUN (white), TSLP (red), DAPI (blue).
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four times with 2 mg tamoxifen (Sigma) or mifepristone (Cayman
Chemical) in DKO*-mT/mG and DKO*K15-mT/mG to induce the
deletion of floxed JunB and c-Jun alleles in the DKO*-mT/mG and
DKO*K15-mT/mG, respectively. In addition, constitutive Tomato
expression was irreversibly replaced by the expression of GFP upon
the removal of the loxP-flanked stop sequence only in the basal
layer of epidermal cells that delete JunB and c-Jun in DKO*-mT/mG,
or only in bulge hair follicle stem cells in the case of DKO*K15-mT/
mG animals.
Intravital imaging
Psoriasis-like DKO*-mT/mG mice at day 7 after tamoxifen induction
were anaesthetized with vaporized isoflurane and placed in a hand-
made platform for the mounting of the ear into a coverslip until it
was completely flattened and immobile. Mice were well hydrated by
a subcutaneous injection of 1 ml saline, and their temperature was
kept at 35°C in a microscope incubator equipped with an air heater
and temperature probe (The Cube, Life Imaging Services). Mice
were provided with vaporized isofluorane at 1.5% through a nose
cone for the course of the live imaging session during 8 h.
All mice were imaged with a TCS-SP5 confocal microscope (Leica
Microsystems) equipped with AOBS and a HCX PLAN APO 20×/0.7
N.A. dry objective. EGFP and TdTomato emission were acquired
every 10 min. Image processing, measurements, assembly, and
editing of time-lapse movies were performed using Image J.
Immunofluorescence
Serial sections from human scalp biopsies and mouse ears embed-
ded in OCT or human scalp biopsies embedded in formalin-fixed
paraffin were processed for immunofluorescence. Frozen sections
were fixed with neutral buffered 4% paraformaldehyde (PFA) for
15 min at room temperature (RT) and washed three times with
phosphate-buffered saline (PBS). Paraffin sections were processed
for their deparaffinization and antigen retrieval. Primary antibodies
specific for c-Jun (Cell Signaling, clone 60A8, ref # 9165, dilution
1:100), JunB (Cell Signaling, clone C37F9, ref # 3753, dilution
1:100), Keratin 15 (Santa Cruz, clone LHK15, dilution 1:400), CD200
(Bio-Rad, ref # MCA1960GA, dilution 1:100), GATA-6 (R&D
Systems, ref # AF1700, dilution 1:400), TSLP (BioLegend, ref #
515901, dilution 1:200), TSLPR (Invitrogen, ref # Pa5-20380, dilu-
tion 1:200), Keratin 5 (BioLegend, ref # 905901, dilution 1:1,000),
cleaved caspase-3 (Cell Signaling, clone Asp175, ref # 9661S, dilu-
tion 1:100), Ki67 (Master Diagnostica, clone SP6, dilution 1:5),
pSTAT3 (Cell Signaling ref # 9145, dilution 1:100), and pSTAT5
(Cell Signaling ref # 9351, dilution 1:100) were incubated overnight
(O/N) at 4°C. Sections were then washed three times with PBS and
incubated with secondary antibodies conjugated to the appropriate
fluorophores (Alexa Fluor 647, Life Technologies, dilution 1:200) for
1 h at RT. Sections were then washed three times with PBS and
mounted with gel mount to be analyzed by fluorescence microscopy
or confocal.
For whole-mount immunostaining, ear skin was dissected, fixed
in 4% paraformaldehyde O/N at 4°C, and washed three times in
PBS. The samples were incubated in 1.5% Triton X-100 and 0.1%
Tween in PBS (PBS-TT) for 3 h at RT. Then, samples were blocked
with 10% donkey serum in PBS-TT (blocking buffer) O/N at RT.
Primary antibody for staining bulge hair follicle stem cells, CD34
(BD PharmingenTM, clone RAM34, ref # 553731, dilution 1:100), was
diluted in blocking buffer and incubated 24 h at RT. After the stain-
ing, samples were washed three times during 6 h in PBS-TT. For
immunofluorescence detection, the samples were incubated in
blocking buffer containing Alexa-647-conjugated secondary antibod-
ies for 24 h at RT. After three washes as described previously, the
samples were stained with Hoechst (1:500) O/N at 4°C. Three
washes with PBS-TT were performed, and samples were kept in
glycerol at 80° for confocal microscopy imaging.
Flow cytometry analysis and FACS
To obtain fresh dissociated epidermal cells from ear skin of psoria-
sis-like and control mice, the epidermis was separated from the
dermis by trypsin digestion (0.75%) for 1 h at 37°C. After mechani-
cal dissociation, the cell suspension was filtered through a 70 lm
cell strainer and centrifuged 5 min at 445 g. Pellet was re-suspended
in culture medium for further flow cytometry analysis or FACS
depends on experiment.
Analysis of different epidermal subpopulations by flow cytometry
was carried out. Epidermal cells were counted, centrifuged and re-
suspended in PBS with 1% chelated FBS and 1% BSA (staining
buffer), and stained for 30–45 min at 4°C with the following conju-
gated surface markers depending on the experiment: CD45-APC-Cy7
(BioLegend, clone 30-F11, dilution 1:400), CD31-PerCP/Cy5.5
(BioLegend, dilution 1:100), CD49f-PE-Cy7 (BioLegend, dilution
1:400), CD34-Alexa-647 (BD PharmingenTM, clone RAM34, dilution
1:100), Sca-1-PerCP/Cy5.5 (BioLegend, clone D7, dilution 1:400),
CD3e-PE-Cy7 (BioLegend, dilution 1:100), CD11b-FITC (BioLegend,
dilution 1:100), CD11c-APC (BioLegend, dilution 1:100), and Ly6G-
PeRP/Cy5.5 (BioLegend, dilution 1:100). EdU staining was carried
out following the manufacturing protocol (Click-iT Plus EdU Alexa
Fluor 647 Flow cytometry Assay Kit, Molecular probes, # C10634).
After staining, cells were washed with staining buffer, stained
with DAPI to exclude dead cells, and analyzed by FACS CANTO II
(BD, San Jose CA). At least 25,000 alive single events were
collected. All data are analyzed using FlowJo 7.6.5 (Treestar,
Oregon).
Sorting of different epidermal subpopulations (basal keratino-
cytes and hair follicle stem cells) was performed after carrying out
the staining explained above. After staining, cells were filtered
through a 40 lm cell strainer onto 5 ml polypropylene sterile tubes.
Sorting procedures were done excluding dead cells and doublets.
GFP+ and Tomato+ epidermal basal keratinocytes and hair follicle
stem cells were purified into TRIzol LS for RNA isolation, or into cell
lysis buffer 1× (Cell Signaling, ref # 9803S) for ELISAs, or collected
in keratinocyte serum-free medium with growth factors (KGM, Invit-
rogen) for primary keratinocyte cultures.
Primary cultures and live-cell imaging
For keratinocyte colony formation assay, basal keratinocytes and
hair follicle stem cells sorted by FACS were cultured in a 12-well
culture plate treated with Coating Matrix Kit (Cascade Biologicals)
in KGM (Invitrogen) in a concentration of 500 cells/cm2. After
10 days in cultures, Tomato+ and GFP+ colonies of keratinocytes
were quantified by fluorescence microscopy. Isolated keratinocytes
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and keratinocyte colonies formed by less of 10 cells were discarded
in this study. Three independent experiments with technical dupli-
cates were performed for statistical analysis.
For live-cell time-lapse imaging of purified single cultures or co-
cultures of Tomato+ and GFP+ keratinocytes, fresh isolated epider-
mal cells from ear skin of psoriatic-like DKO* or control mice were
cultured in KGM in a 24-well culture plate treated with Coating
Matrix Kit in a concentration of 2,000 cells/cm2. Each type of
epidermal subpopulation was cultured alone, or in contact co-
cultures (1:1 proportion) of mutantGFP cell with non-mutantTom
cells or in co-cultures using 12-well trans-well system, in which
non-mutantTom cells were cultured in the bottom and mutantGFP
cells were cultured in the insert. Time-lapse images were captured
using CCD confocal incubator microscope at 37°C and 5% CO2.
Images of small colonies formed after 3–5 days in culture from
alone GFP+ epidermal cells, or co-cultures of GFP+: Tomato+ kera-
tinocytes were captured with 20× objective as six selected fields
where keratinocyte colonies were located in 15-min intervals for
48 h. Images of Tomato+ keratinocytes from trans-well experiments
were captured each 48 h during 6 days. Cell death was analyzed by
TOPRO-3 and DAPI staining. Image processing, measurements,
assembly, and editing of time-lapse movies were performed using
Image J. Three independent experiments were performed for statis-
tical analysis.
To recombinant TSLP treatment, fresh isolated epidermal cells
from ear and tail skin or purified bulge HF-SCs and basal KCs of WT
mice were cultured in KGM in a 24-well culture plate treated with
Coating Matrix Kit in a concentration of 10,000 cells/cm2. Next day,
mouse recombinant TSLP (eBioscence, ref # 14-8498-80) was added
at different concentrations during 48 h. 5-Ethynyl-20-deoxyuridine
(EdU) was added to the cultures after 2 days with mouse recombi-
nant TSLP in a concentration of 10 lM during 5 h at 37°C. EdU and
anti-TSLPR staining was performed, and random confocal images
were captures. EdU+ keratinocytes were quantified by Image J.
Three independent experiments were performed for statistical
analysis.
Adenovirus infection and TSLP neutralization
Fresh dissociated epidermal cells from ear and tail epidermis of
adult JunBf/f c-Junf/f RosamT/mGf/f mice were plated in a 24-well
culture plate treated with Coating Matrix Kit (Cascade Biologicals)
in KGM (Invitrogen) in a concentration of 15,000 cells/cm2.
Twenty-four hours later, JunBf/f c-Junf/f RosamT/mGf/f keratinocyte
cultures were infected with adenoviruses expressing Cre (Ad-cre) or
empty (Ad-empty) purchased from the University of lowa in a
concentration of 3 × 106 particles of virus per ml of KGM. The
medium with adenoviruses was changed by fresh KGM 16 h after
infection. Two days after infection, around 50–60% of primary kera-
tinocytes became GFP positive and the rest were Tomato positive
and anti-TSLP antibody (PROALT-Protein Alternatives S.L, clone
28F12) was added to the cells every day during three consecutive
days in a concentration of 500 ng/ml or 1 lg/ml. Mouse IgG was
added in parallel as control. 5-Ethynyl-20-deoxyuridine (EdU) was
added to the cultures after 3 days with anti-TSLP antibody in a
concentration of 10 lM during 5 h at 37°C. For further analysis,
cells were fixed with PFA 4% in PBS for EdU staining (Thermo
Fisher, C10086) or they were harvested for RNA isolation from total
cultures or from purified GFP+ and Tom+ KCs by FACS. Condi-
tioned medium was also harvested to quantify soluble TSLP by
ELISA according to the manufacturer’s instructions (Mouse TSLP
Quantikine ELISA Kit, Ref # MTLP00, R&D Systems). Conditioned
medium was diluted to 1:50.
In vivo neutralization of TSLP was performed by three intradermal
injections of 20 lg of ab-TSLP or IgG each 72 h on the right ear of
DKO* and DKO*15 5 days after psoriasis-like induction. Left ears were
injected with PBS. EdU was applied to mice by IP injection 2 h before
euthanasia. FACS analyses were performed as described above.
RNA isolation and qPCRs
After FACS, each purified epidermal subpopulation was collected in
TRIzol LS (Thermo Fisher Scientific) for further RNA isolation as
described by manufacturer’s instructions. RNA extraction was
followed by reverse transcription using Promega kit (A2801). qPCR
analyses were carried out using SYBR Green Master Mix Kit (Qia-
gen, 204143). Expression levels were compared to housekeeping
gene RPL4. The primer sequences are shown in Appendix Table S1.
RNA-seq
Whole-genome transcriptomic analysis was performed by Next-Gen
RNA-sequencing in four groups of psoriatic-like epidermal subpopu-
lations after FACS and RNA isolation described above: MutantGFP,
non-mutantTom basal keratinocytes, mutantGFP, and non-mutantTom
hair follicle stem cells were purified from the ears of three indepen-
dent psoriatic-like DKO* mice after 7 days of tamoxifen induction.
RNA-seq was also performed in control basal keratinocytes and hair
follicle stem cells from the ears of three Co-mT/mG mice for further
analysis. Next-Gen library construction and sequencing procedures
were carried out by the Genomic Unit at CNIO, and further analysis
was carried out by Bioinformatics Unit at CNIO. After confirmation
of RNA quality by Agilent 2100 Bioanalyzer, variable amounts of
total RNA samples, between 4 and 10 ng, were processed with the
SMART-Seq v4 Ultra Low input RNA Kit (Clontech) by following
manufacturer’s instructions. Briefly, oligo(dT) primes preferentially
reverse transcription of poly(A) RNA in the presence of a template
switching oligonucleotide, and then, limited-cycle PCR produces
double-stranded cDNA. Resulting cDNA was subsequently
processed with the “Nextera XT DNA Library Prep Kit” (Illumina),
which fragments and inserts Illumina adapters. Adapter-ligated non-
directional libraries were completed by 12 cycles of PCR.
The resulting purified cDNA library was applied to an Illumina
flow cell for cluster generation and sequenced on an Illumina HiSeq
2500 following manufacturer’s protocols. Fifty-one base single-end
sequencing reads were analyzed with the nextpresso pipeline (Grana
et al, 2017), as follows: Sequencing quality was checked with
FastQC v0.11.0 (http://www.bioinformatics.babraham.ac.uk/projec
ts/fastqc/). Reads were aligned to the mouse genome (NCBI37/
mm9) with TopHat-2.0.10 (Trapnell et al, 2012) using Bowtie 1.0.0
(Langmead et al, 2009) and SAMtools 0.1.19 (Li et al, 2009), allow-
ing two mismatches and 20 multihits. Differential expression was
tested with Cufflinks (Trapnell et al, 2012), using the mouse
NCBI37/mm9 transcript annotations from https://ccb.jhu.edu/sof
tware/tophat/igenomes.shtml. GSEAPreranked (Subramanian et al,
2005) was used to perform gene set enrichment analysis of the
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described gene signatures on a pre-ranked gene list, setting 1,000
gene set permutations. Differentially expressed genes (DEGs) were
further analyzed for Venn’s diagram (Venny2.1, http://bioinfogp.
cnb.csic.es/tools/venny/), Gene Ontology Biological Process
(Enrichr, http://amp.pharm.mssm.edu/Enrichr/), and predictable
secreted proteins (ProteINSIDE, http://www.proteinside.org/).
Statistical analyses
For studies including animals, n is the number of total animals
tested, and for in vitro studies, the number of independent experi-
mental replicates is indicated in Figure legends, with n representing
number of repeats with different sets of cells. For RNA-seq, three
control mice and 3 DKO* mice were used. Data in bar graphs repre-
sent mean  standard deviation (SD). Statistical analyses were
performed using Prism5 (GraphPad) software. When comparing two
groups, a two-tailed Student’s t-test was used, and to compare three
or more groups, a two-way ANOVA and Bonferroni post-test was
implemented. P-values were calculated with a confidence interval of
95% to indicate the statistical significance between groups. Statisti-
cally significant differences between groups are noted in figures
with asterisks (*P < 0.05, **P < 0.01, ***P < 0.001).
Data availability
All primary data, detailed protocols, and non-commercially avail-
able materials can be requested from the corresponding author. The
RNA-seq datasets have been deposited to GEO under the accession
number GSE119762 (https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE119762).
Expanded View for this article is available online.
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